Long non-coding RNA NRAV enhances proliferation and invasion of hepatocellular carcinoma cells by modulating the Wnt/β-catenin signaling pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789.
   Web of Science ®Google Scholar
• Liu Z, Liu X, Liang J, et al. Immunotherapy for Hepatocellular Carcinoma: current Status and Future Prospects. Front Immunol. 2021;12:765101.
   PubMed Web of Science ®Google Scholar
• Chen Z, Xie H, Hu M, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020;10(9):2993–3036.
   PubMed Web of Science ®Google Scholar
• Vogel A, Saborowski A. Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. Cancer Treat Rev. 2020;82:101946.
   PubMed Web of Science ®Google Scholar
• Lurje I, Czigany Z, Bednarsch J, et al. Treatment strategies for hepatocellular carcinoma - a multidisciplinary approach. Int J Mol Sci. 2019;20(6):1465.
   Web of Science ®Google Scholar
• Cauchy F, Fuks D, Belghiti J. HCC: current surgical treatment concepts. Langenbecks Arch Surg. 2012;397(5):681–695.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154(1):26–46.
   PubMed Web of Science ®Google Scholar
• Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223–227.
   PubMed Web of Science ®Google Scholar
• Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651–669.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407.
   PubMed Web of Science ®Google Scholar
• Li J, Meng H, Bai Y, et al. Regulation of lncRNA and its role in cancer metastasis. Oncol Res. 2016;23(5):205–217.
   PubMed Web of Science ®Google Scholar
• Chan JJ, Tay Y. Noncoding RNA: RNA Regulatory Networks in Cancer. Int J Mol Sci. 2018;19(5):1310.
   PubMed Web of Science ®Google Scholar
• Renganathan A, Felley-Bosco E. Long noncoding RNAs in cancer and therapeutic potential. Adv Exp Med Biol. 2017;1008:199–222.
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang D, Wang J, et al. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019;8(9):1015.
   Web of Science ®Google Scholar
• Feng Y, Hu X, Ma K, et al. Genome-wide screening identifies prognostic long noncoding RNAs in hepatocellular carcinoma. Biomed Res Int. 2021;2021:6640652.
   PubMed Web of Science ®Google Scholar
• Xu Q, Wang Y, Huang W. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma. Int Immunopharmacol. 2021;92:107333.
   PubMed Web of Science ®Google Scholar
• Chen ZA, Tian H, Yao DM, et al. Identification of a ferroptosis-related signature model including mRNAs and lncRNAs for predicting prognosis and immune activity in hepatocellular carcinoma. Front Oncol. 2021;11:738477.
   PubMed Web of Science ®Google Scholar
• Li J, Li M, Wang X, et al. Long noncoding RNA NRAV promotes respiratory syncytial virus replication by targeting the microRNA miR-509-3p/Rab5c axis to regulate vesicle transportation. J Virol. 2020;94(10). DOI:10.1128/JVI.00113-20.
   Web of Science ®Google Scholar
• Ouyang J, Zhu X, Chen Y, et al. NRAV, a long noncoding RNA, modulates antiviral responses through suppression of interferon-stimulated gene transcription. Cell Host Microbe. 2014;16(5):616–626.
   PubMed Web of Science ®Google Scholar
• Li M, Liao H, Wu J, et al. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1. Bioengineered. 2021;12(2):12880–12890.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Xu Q, Xu N. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway. Bioengineered. 2021;12(1):7964–7974.
   PubMed Web of Science ®Google Scholar
• Miao YR, Liu W, Zhang Q, et al. lncRNASNP2: an updated database of functional SNPs and mutations in human and mouse lncRNAs. Nucleic Acids Res. 2018;46(D1):D276–d80.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–7.
   PubMed Web of Science ®Google Scholar
• Nusse R, Clevers H. Wnt/β-Catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–999.
   PubMed Web of Science ®Google Scholar
• Yang Y, Bai YS, Wang Q. CDGSH iron sulfur domain 2 activates proliferation and EMT of pancreatic cancer cells via Wnt/β-catenin pathway and has prognostic value in human pancreatic cancer. Oncol Res. 2017;25(4):605–615.
   PubMed Web of Science ®Google Scholar
• Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179(5):1033–1055.
   PubMed Web of Science ®Google Scholar
• Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18.
   PubMed Web of Science ®Google Scholar
• Zhao JT, Chi BJ, Sun Y, et al. LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR-320/S100A10 axis. Cell Biochem Funct. 2020;38(7):859–869.
   PubMed Web of Science ®Google Scholar
• Wang Y, He L, Du Y, et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015;16(4):413–425.
   PubMed Web of Science ®Google Scholar
• Hongfeng Z, Andong J, Liwen S, et al. lncRNA RMRP knockdown suppress hepatocellular carcinoma biological activities via regulation miRNA-206/TACR1. J Cell Biochem. 2020;121(2):1690–1702.
   PubMed Web of Science ®Google Scholar
• Henry JC, Park JK, Jiang J, et al. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2010;403(1):120–125.
   PubMed Web of Science ®Google Scholar
• Guan J, Liu Z, Xiao M, et al. MicroRNA-199a-3p inhibits tumorigenesis of hepatocellular carcinoma cells by targeting ZHX1/PUMA signal. Am J Transl Res. 2017;9(5):2457–2465.
   PubMed Web of Science ®Google Scholar
• Chen YF, Chou TY, Lin IH, et al. Upregulation of Cisd2 attenuates Alzheimer’s-related neuronal loss in mice. J Pathol. 2020;250(3):299–311.
   PubMed Web of Science ®Google Scholar
• Sun AG, Meng FG, Wang MG. CISD2 promotes the proliferation of glioma cells via suppressing beclin‑1‑mediated autophagy and is targeted by microRNA‑449a. Mol Med Rep. 2017;16(6):7939–7948.
   PubMed Web of Science ®Google Scholar
• Wu D, Talbot CC Jr., Liu Q, et al. Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension. J Mol Med (Berl). 2016;94(8):875–885.
   PubMed Web of Science ®Google Scholar
• El-Derany MO, Noureldein MH. Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo. Stem Cell Res Ther. 2021;12(1):322.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Khoshbakht T, Bahranian A, et al. CircMTO1: a circular RNA with roles in the carcinogenesis. Biomed Pharmacother. 2021;142:112025.
   PubMed Web of Science ®Google Scholar
• He S, Tang S. WNT/β-catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020;132:110851.
   PubMed Web of Science ®Google Scholar
• Bian J, Dannappel M, Wan C, et al. Transcriptional regulation of Wnt/β-Catenin pathway in colorectal cancer. Cells. 2020;9(9):2125.
   PubMed Web of Science ®Google Scholar
• Sebio A, Kahn M, Lenz HJ. The potential of targeting Wnt/β-catenin in colon cancer. Expert Opin Ther Targets. 2014;18(6):611–615.
   PubMed Web of Science ®Google Scholar